Menu Search
Equities

Novartis AG

NOVNEE:SWX

Novartis AG

Actions
  • Price (CHF)84.45
  • Today's Change-0.41 / -0.48%
  • Shares traded70.95k
  • 1 Year change-4.53%
  • Beta--
Data delayed at least 15 minutes, as of Apr 19 2024 10:06 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		NOVN:SWX since
announced		Transaction
value
IFM Due IncAnnounced13 Mar 202413 Mar 2024Announced-3.77%835.00m
Cytokinetics IncRumoured08 Jan 202408 Jan 2024Rumoured-6.77%--
Calypso Biotech BVAnnounced08 Jan 202408 Jan 2024Announced-6.77%425.00m
SanReno TherapeuticsDeal completed05 Jan 202405 Jan 2024Deal completed-6.18%--
DTx Pharma IncDeal completed17 Jul 202317 Jul 2023Deal completed-0.79%500.00m
Data delayed at least 15 minutes, as of Apr 19 2024 10:13 BST.

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Pyrford International Ltd.as of 30 Jun 2022193.08k0.00%
LUKB Expert Fondsleitung AGas of 31 Jul 202364.69k0.00%
Voya Investment Management Co. LLCas of 29 Feb 202431.16k0.00%
Swiss Rock Asset Management AGas of 30 Jun 202319.61k0.00%
Nomura Asset Management Co., Ltd.as of 29 Mar 202410.40k0.00%
AQR Capital Management LLCas of 30 Sep 20205.12k0.00%
JPMorgan Asset Management (China) Co Ltd.as of 30 Jun 20232.65k0.00%
CA Indosuez Wealth (Private Banking Europe)as of 30 Jun 20210.000.00%
More ▼
Data from 30 Jun 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.